Value & Access Head Greece

Major Accountabilities:

• Developing and operationalizing the Integrated Product Access strategy
• Create and champion a compelling and competitive international strategic vision for how Novartis will innovate and expand access through DAs for the benefit of patients, Healthcare Systems, Payers, and Novartis
• Active leadership in internal fora - enable broad country insights and alignment, and leverage external fora (e.g., EMA/EUnetHTA & advisory boards) to pressure-test strategies, level of evidence etc. for feasibility and success.
• With the TA, develop the international integrated product access strategy (IPAS) to deliver product differentiation most relevant to payers (e.g., well-defined target population, clinical endpoints, comparators, outcome measures, utility instruments, Health Economics data), patients, and HCS stakeholders worldwide.
• Ensure that at launch, Novartis brands are supported by a robust payer value proposition particularly featuring core elements; ‘Value for money’ story, strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis.
• Ensure access team develops and represents expert value evidence input into TPPs, clinical programs (including IEPs), BD&Ls, and develop any additional non-registration evidence to meet the needs of medical experts and institutions involved in reimbursement & access decisions for key geographies.
• Collaborate with the HEOR & PCO team to ensure full integration of adequate HEOR/evidence deliverables in high quality cross-franchise strategy. Ensure appropriate focus on priority markets needs into overall strategy.
• Determine payer evidence requirements, risks/opportunities in the access landscape and create compelling access strategy with the TA and provide the “access toolbox” to share with priority markets, major HTA archetypes and Budget Impact archetypes.
• Ensure appropriate and timely access input into BD&Ls, asset maximization incl. indication sequencing.
• Maximize value of Novartis assets by creating and executing, together with TAs & pricing team, winning pricing strategies, global pricing guidance, incl. MEAs, PSPs, rigorous international pricing governance.
• Stay abreast of internal and external developments, trends and other dynamics that affect the wider health policy and access domains, as well as of relevant scientific, clinical, and commercial developments.
• Collaborate with S&G and Development to drive consistent and access-optimal approaches to product shaping, value propositions and HCS value creation.
• Analyze and anticipate changes in priority international markets, major HTA archetypes and Budget Impact archetypes to model future expenditures and project critical market access assumptions.
• Disseminate value of medicines to HCS decision-makers with focus on international forums and publications in collaboration with international or regional policy groups.
• Manage Access community and budgets.
• Effectively work in matrix balancing cross-functional perspectives and alignment with business priorities against flexible resourcing.
• Reporting of technical complaints / adverse events / special case scenarios related to Novartis products within 24 hours of receipt
• Distribution of marketing samples (where applicable)

Key performance indicators:

• Reimbursement/listing status, price versus targets, time to reimbursement/access
• Revenue, market availability/access

REQUIREMENTS:

Must have:

• 5+ years of experience in market access roles
• 2+ years global or ex-US regional experience
• Experience working early in drug development lifecycle
• Product launch experience
• Cross functional and matrix influential experience across a team of multiple stakeholders
• Experience in driving commercial strategy driven through access or HEOR or pricing expertise

Preferred:

• 7+ years of experience in market access roles
• MBA, Ph.D., M.D. or RPh
• 5+ years global or ex-US regional experience
• Ex-US country experience
• 2+ years of experience in the relevant therapeutic area
• Strong external network with thought leaders and influencers in the payer and HTA environment

Key Leadership Capabilities required:

• Demonstrates strong communication skills and can influence across a range of diverse stakeholders to drive change
• Balances strategy and operational excellence to ensure end to end execution of the strategy
• Effectively balances the needs of various stakeholders and defines priorities based on highest impact for business and patients
• Strong solution-orientation and enterprise mindset
• Competitive and entrepreneurial mindset with proven track record of fostering innovation

Skills:

• Access And Reimbursement Strategy.
• Agility.
• Analytical Skill.
• Analytical Thinking.
• Cross-Functional Collaboration.
• Customer-Centric Mindset.
• Employee Development.
• Finance.
• Go-To-Market Strategy.
• Health Economics.
• Health Policy.
• Health Technology Assessment (Hta).
• Healthcare Sector Understanding.
• Influencing Skills.
• Innovation.
• Inspirational Leadership.
• Lcm Strategy.
• Market Access Strategy.
• Negotiation Skills.
• People Management.
• Pricing Strategy.
• Process Management.
• Product Launches.
• Project Management.
• Public Affairs.
• Real-World Evidence (Rwe).
• Regulatory Compliance.
• Results Oriented.
• Risk Management.
• Stakeholder Engagement.
• Strategic Partnerships.

• Value Propositions.

Languages:

• English.